Conquering Diseases

A Study Of A Combination Of Oral Drugs In Advanced, Recurrent Or Metastatic Endometroid Endometrial Cancer

Description

Seeking women over 18 years of age who have been diagnosed with advanced, recurrent or metastatic endometroid endometrial cancer for the study of a combination of oral drugs for this type of cancer.

Overview

The purpose of this study is to find out of the combination of the drugs being used is better or worse than usual approach for this type of caner. The usual approach is defined as care most people get for endometrial cancer. Another purpose of the study is to test any good and bad effects of the drug being used in combination.

What we're hoping for

To better understand how this combination of drugs used in this study will affect advanced, recurrent or metastatic endometroid endometrial cancer, and to determine how well this combination of drugs are tolerated for these participants.

Additional Information

ClinicalTrials.gov Identifier: NCT04393285

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989